Khan Fazal R. 4
4 · MERRIMACK PHARMACEUTICALS INC · Filed Dec 17, 2012
Insider Transaction Report
Form 4
Khan Fazal R.
SVP of Manufacturing
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2012-12-17−25,000→ 100,000 totalExercise: $1.71Exp: 2016-02-24→ Common Stock (25,000 underlying) - Sale
Common Stock
2012-12-13$6.73/sh−25,000$168,320→ 0 total - Exercise/Conversion
Common Stock
2012-12-17$1.71/sh+25,000$42,750→ 25,000 total - Exercise/Conversion
Stock Option (right to buy)
2012-12-13−25,000→ 125,000 totalExercise: $1.71Exp: 2016-02-24→ Common Stock (25,000 underlying) - Exercise/Conversion
Common Stock
2012-12-13$1.71/sh+25,000$42,750→ 25,000 total - Sale
Common Stock
2012-12-17$6.41/sh−25,000$160,343→ 0 total
Footnotes (1)
- [F1]This option is fully vested.